APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galectin 3

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Galectin 3 Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchGalectin 3 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Galectin 3 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Galectin 3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galectin 3 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Galectin 3 Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Galectin 3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galectin 3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Galectin 3 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Galectin 3 market include MandalMed Inc, iTeos Therapeutics SA, GlycoMimetics Inc, Galectin Therapeutics Inc, Bristol-Myers Squibb Company and Angion Biomedica Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Galectin 3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galectin 3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galectin 3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galectin 3 market size, projected growth trends, production technologies, key applications, and end-use industries.

Galectin 3 Segment by Company

MandalMed Inc

iTeos Therapeutics SA

GlycoMimetics Inc

Galectin Therapeutics Inc

Bristol-Myers Squibb Company

Angion Biomedica Corp

Galectin 3 Segment by Type

KTI

GRMD-03

GAL-300

ANG-4021

Others

Galectin 3 Segment by Application

Metastatic Melanoma

Portal Hypertension

Liver Cirrhosis

Others

Galectin 3 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Galectin 3 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Galectin 3 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Galectin 3 significant trends, drivers, influence factors in global and regions.

6. To analyze Galectin 3 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galectin 3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galectin 3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galectin 3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galectin 3 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Galectin 3 industry.

Chapter 3: Detailed analysis of Galectin 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Galectin 3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Galectin 3 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Galectin 3 Industry Trends Table 2. Galectin 3 Industry Drivers Table 3. Galectin 3 Industry Opportunities and Challenges Table 4. Galectin 3 Industry Restraints Table 5. Global Galectin 3 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Galectin 3 Revenue Share by Company (2021-2026) Table 7. Global Galectin 3 Sales Volume by Company (k units) & (2021-2026) Table 8. Global Galectin 3 Sales Volume Share by Company (2021-2026) Table 9. Global Galectin 3 Average Price (US$/unit) of Company (2021-2026) Table 10. Global Galectin 3 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Galectin 3 Key Company Manufacturing Base & Headquarters Table 12. Global Galectin 3 Company, Product Type & Application Table 13. Global Galectin 3 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Galectin 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of KTI Table 18. Significant Companies of GRMD-03 Table 19. Significant Companies of GAL-300 Table 20. Significant Companies of ANG-4021 Table 21. Significant Companies of Others Table 22. Global Galectin 3 Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Galectin 3 Sales Volume by Type (2021-2026) & (k units) Table 24. Global Galectin 3 Sales Volume by Type (2027-2032) & (k units) Table 25. Global Galectin 3 Sales Volume Share by Type (2021-2026) Table 26. Global Galectin 3 Sales Volume Share by Type (2027-2032) Table 27. Global Galectin 3 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Galectin 3 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Galectin 3 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Galectin 3 Sales Value Share by Type (2021-2026) Table 31. Global Galectin 3 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Metastatic Melanoma Table 33. Significant Companies of Portal Hypertension Table 34. Significant Companies of Liver Cirrhosis Table 35. Significant Companies of Others Table 36. Global Galectin 3 Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Galectin 3 Sales Volume by Application (2021-2026) & (k units) Table 38. Global Galectin 3 Sales Volume by Application (2027-2032) & (k units) Table 39. Global Galectin 3 Sales Volume Share by Application (2021-2026) Table 40. Global Galectin 3 Sales Volume Share by Application (2027-2032) Table 41. Global Galectin 3 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Galectin 3 Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Galectin 3 Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Galectin 3 Sales Value Share by Application (2021-2026) Table 45. Global Galectin 3 Sales Value Share by Application (2027-2032) Table 46. Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Galectin 3 Sales by Region (2021-2026) & (k units) Table 48. Global Galectin 3 Sales Market Share by Region (2021-2026) Table 49. Global Galectin 3 Sales by Region (2027-2032) & (k units) Table 50. Global Galectin 3 Sales Market Share by Region (2027-2032) Table 51. Global Galectin 3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Galectin 3 Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Galectin 3 Sales Value Share by Region (2021-2026) Table 54. Global Galectin 3 Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Galectin 3 Sales Value Share by Region (2027-2032) Table 56. Global Galectin 3 Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Galectin 3 Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Galectin 3 Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Galectin 3 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Galectin 3 Sales by Country (2021-2026) & (k units) Table 61. Global Galectin 3 Sales Market Share by Country (2021-2026) Table 62. Global Galectin 3 Sales by Country (2027-2032) & (k units) Table 63. Global Galectin 3 Sales Market Share by Country (2027-2032) Table 64. Global Galectin 3 Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Galectin 3 Sales Value Market Share by Country (2021-2026) Table 66. Global Galectin 3 Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Galectin 3 Sales Value Market Share by Country (2027-2032) Table 68. MandalMed Inc Company Information Table 69. MandalMed Inc Business Overview Table 70. MandalMed Inc Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. MandalMed Inc Galectin 3 Product Portfolio Table 72. MandalMed Inc Recent Development Table 73. iTeos Therapeutics SA Company Information Table 74. iTeos Therapeutics SA Business Overview Table 75. iTeos Therapeutics SA Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. iTeos Therapeutics SA Galectin 3 Product Portfolio Table 77. iTeos Therapeutics SA Recent Development Table 78. GlycoMimetics Inc Company Information Table 79. GlycoMimetics Inc Business Overview Table 80. GlycoMimetics Inc Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GlycoMimetics Inc Galectin 3 Product Portfolio Table 82. GlycoMimetics Inc Recent Development Table 83. Galectin Therapeutics Inc Company Information Table 84. Galectin Therapeutics Inc Business Overview Table 85. Galectin Therapeutics Inc Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Galectin Therapeutics Inc Galectin 3 Product Portfolio Table 87. Galectin Therapeutics Inc Recent Development Table 88. Bristol-Myers Squibb Company Company Information Table 89. Bristol-Myers Squibb Company Business Overview Table 90. Bristol-Myers Squibb Company Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bristol-Myers Squibb Company Galectin 3 Product Portfolio Table 92. Bristol-Myers Squibb Company Recent Development Table 93. Angion Biomedica Corp Company Information Table 94. Angion Biomedica Corp Business Overview Table 95. Angion Biomedica Corp Galectin 3 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Angion Biomedica Corp Galectin 3 Product Portfolio Table 97. Angion Biomedica Corp Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Galectin 3 Distributors List Table 101. Galectin 3 Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Galectin 3 Product Image Figure 2. Global Galectin 3 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Galectin 3 Sales (2021-2032) & (k units) Figure 5. Global Galectin 3 Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Galectin 3 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. KTI Image Figure 10. GRMD-03 Image Figure 11. GAL-300 Image Figure 12. ANG-4021 Image Figure 13. Others Image Figure 14. Global Galectin 3 Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Galectin 3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Galectin 3 Sales Volume Share by Type (2021-2032) Figure 17. Global Galectin 3 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Galectin 3 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Galectin 3 Sales Value Share by Type (2021-2032) Figure 20. Metastatic Melanoma Image Figure 21. Portal Hypertension Image Figure 22. Liver Cirrhosis Image Figure 23. Others Image Figure 24. Global Galectin 3 Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Galectin 3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Galectin 3 Sales Volume Share by Application (2021-2032) Figure 27. Global Galectin 3 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Galectin 3 Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Galectin 3 Sales Value Share by Application (2021-2032) Figure 30. Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Galectin 3 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Galectin 3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Galectin 3 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 35. North America Galectin 3 Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Galectin 3 Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Galectin 3 Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 41. South America Galectin 3 Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Galectin 3 Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Galectin 3 Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Galectin 3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Galectin 3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Galectin 3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Galectin 3 Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Galectin 3 Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • KTI
  • GRMD-03
  • GAL-300
  • ANG-4021
  • Others
Applications
  • Metastatic Melanoma
  • Portal Hypertension
  • Liver Cirrhosis
  • Others
Companies covered
  • MandalMed Inc
  • iTeos Therapeutics SA
  • GlycoMimetics Inc
  • Galectin Therapeutics Inc
  • Bristol-Myers Squibb Company
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galectin 3 Sales Value (2021-2032)
  4. 1.2.2 Global Galectin 3 Sales Volume (2021-2032)
  5. 1.2.3 Global Galectin 3 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Galectin 3 Market Dynamics
  1. 2.1 Galectin 3 Industry Trends
  2. 2.2 Galectin 3 Industry Drivers
  3. 2.3 Galectin 3 Industry Opportunities and Challenges
  4. 2.4 Galectin 3 Industry Restraints
3 Galectin 3 Market by Company
  1. 3.1 Global Galectin 3 Company Revenue Ranking in 2025
  2. 3.2 Global Galectin 3 Revenue by Company (2021-2026)
  3. 3.3 Global Galectin 3 Sales Volume by Company (2021-2026)
  4. 3.4 Global Galectin 3 Average Price by Company (2021-2026)
  5. 3.5 Global Galectin 3 Company Ranking (2024-2026)
  6. 3.6 Global Galectin 3 Company Manufacturing Base and Headquarters
  7. 3.7 Global Galectin 3 Company Product Type and Application
  8. 3.8 Global Galectin 3 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Galectin 3 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Galectin 3 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Galectin 3 Market by Type
  1. 4.1 Galectin 3 Type Introduction
  2. 4.1.1 KTI
  3. 4.1.2 GRMD-03
  4. 4.1.3 GAL-300
  5. 4.1.4 ANG-4021
  6. 4.1.5 Others
  7. 4.2 Global Galectin 3 Sales Volume by Type
  8. 4.2.1 Global Galectin 3 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Galectin 3 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Galectin 3 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Galectin 3 Sales Value by Type
  12. 4.3.1 Global Galectin 3 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Galectin 3 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Galectin 3 Sales Value Share by Type (2021-2032)
5 Galectin 3 Market by Application
  1. 5.1 Galectin 3 Application Introduction
  2. 5.1.1 Metastatic Melanoma
  3. 5.1.2 Portal Hypertension
  4. 5.1.3 Liver Cirrhosis
  5. 5.1.4 Others
  6. 5.2 Global Galectin 3 Sales Volume by Application
  7. 5.2.1 Global Galectin 3 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Galectin 3 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Galectin 3 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Galectin 3 Sales Value by Application
  11. 5.3.1 Global Galectin 3 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Galectin 3 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Galectin 3 Sales Value Share by Application (2021-2032)
6 Galectin 3 Regional Sales and Value Analysis
  1. 6.1 Global Galectin 3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Galectin 3 Sales by Region (2021-2032)
  3. 6.2.1 Global Galectin 3 Sales by Region: 2021-2026
  4. 6.2.2 Global Galectin 3 Sales by Region (2027-2032)
  5. 6.3 Global Galectin 3 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Galectin 3 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Galectin 3 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Galectin 3 Sales Value by Region (2027-2032)
  9. 6.5 Global Galectin 3 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Galectin 3 Sales Value (2021-2032)
  12. 6.6.2 North America Galectin 3 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Galectin 3 Sales Value (2021-2032)
  15. 6.7.2 Europe Galectin 3 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Galectin 3 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Galectin 3 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Galectin 3 Sales Value (2021-2032)
  21. 6.9.2 South America Galectin 3 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Galectin 3 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Galectin 3 Sales Value Share by Country, 2025 VS 2032
7 Galectin 3 Country-level Sales and Value Analysis
  1. 7.1 Global Galectin 3 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Galectin 3 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Galectin 3 Sales by Country (2021-2032)
  4. 7.3.1 Global Galectin 3 Sales by Country (2021-2026)
  5. 7.3.2 Global Galectin 3 Sales by Country (2027-2032)
  6. 7.4 Global Galectin 3 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Galectin 3 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Galectin 3 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Galectin 3 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Galectin 3 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Galectin 3 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Galectin 3 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Galectin 3 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Galectin 3 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Galectin 3 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Galectin 3 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Galectin 3 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Galectin 3 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Galectin 3 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Galectin 3 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Galectin 3 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Galectin 3 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Galectin 3 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Galectin 3 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Galectin 3 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Galectin 3 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Galectin 3 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Galectin 3 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Galectin 3 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Galectin 3 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Galectin 3 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Galectin 3 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Galectin 3 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Galectin 3 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Galectin 3 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Galectin 3 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Galectin 3 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Galectin 3 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Galectin 3 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Galectin 3 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Galectin 3 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Galectin 3 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Galectin 3 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Galectin 3 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Galectin 3 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Galectin 3 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Galectin 3 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Galectin 3 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Galectin 3 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Galectin 3 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Galectin 3 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Galectin 3 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Galectin 3 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Galectin 3 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Galectin 3 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Galectin 3 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Galectin 3 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Galectin 3 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Galectin 3 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Galectin 3 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Galectin 3 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Galectin 3 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Galectin 3 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Galectin 3 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Galectin 3 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Galectin 3 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Galectin 3 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Galectin 3 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Galectin 3 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Galectin 3 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Galectin 3 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Galectin 3 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Galectin 3 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Galectin 3 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Galectin 3 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Galectin 3 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Galectin 3 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Galectin 3 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Galectin 3 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Galectin 3 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Galectin 3 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Galectin 3 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Galectin 3 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Galectin 3 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Galectin 3 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Galectin 3 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Galectin 3 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Galectin 3 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Galectin 3 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Galectin 3 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Galectin 3 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Galectin 3 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MandalMed Inc
  2. 8.1.1 MandalMed Inc Company Information
  3. 8.1.2 MandalMed Inc Business Overview
  4. 8.1.3 MandalMed Inc Galectin 3 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 MandalMed Inc Galectin 3 Product Portfolio
  6. 8.1.5 MandalMed Inc Recent Developments
  7. 8.2 iTeos Therapeutics SA
  8. 8.2.1 iTeos Therapeutics SA Company Information
  9. 8.2.2 iTeos Therapeutics SA Business Overview
  10. 8.2.3 iTeos Therapeutics SA Galectin 3 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 iTeos Therapeutics SA Galectin 3 Product Portfolio
  12. 8.2.5 iTeos Therapeutics SA Recent Developments
  13. 8.3 GlycoMimetics Inc
  14. 8.3.1 GlycoMimetics Inc Company Information
  15. 8.3.2 GlycoMimetics Inc Business Overview
  16. 8.3.3 GlycoMimetics Inc Galectin 3 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlycoMimetics Inc Galectin 3 Product Portfolio
  18. 8.3.5 GlycoMimetics Inc Recent Developments
  19. 8.4 Galectin Therapeutics Inc
  20. 8.4.1 Galectin Therapeutics Inc Company Information
  21. 8.4.2 Galectin Therapeutics Inc Business Overview
  22. 8.4.3 Galectin Therapeutics Inc Galectin 3 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Galectin Therapeutics Inc Galectin 3 Product Portfolio
  24. 8.4.5 Galectin Therapeutics Inc Recent Developments
  25. 8.5 Bristol-Myers Squibb Company
  26. 8.5.1 Bristol-Myers Squibb Company Company Information
  27. 8.5.2 Bristol-Myers Squibb Company Business Overview
  28. 8.5.3 Bristol-Myers Squibb Company Galectin 3 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bristol-Myers Squibb Company Galectin 3 Product Portfolio
  30. 8.5.5 Bristol-Myers Squibb Company Recent Developments
  31. 8.6 Angion Biomedica Corp
  32. 8.6.1 Angion Biomedica Corp Company Information
  33. 8.6.2 Angion Biomedica Corp Business Overview
  34. 8.6.3 Angion Biomedica Corp Galectin 3 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Angion Biomedica Corp Galectin 3 Product Portfolio
  36. 8.6.5 Angion Biomedica Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galectin 3 Value Chain Analysis
  2. 9.1.1 Galectin 3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galectin 3 Sales Mode & Process
  6. 9.2 Galectin 3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galectin 3 Distributors
  9. 9.2.3 Galectin 3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst